Literature DB >> 16297466

Pregnane and Xenobiotic Receptor (PXR/SXR) resides predominantly in the nuclear compartment of the interphase cell and associates with the condensed chromosomes during mitosis.

Mallampati Saradhi1, Aniruddha Sengupta, Gauranga Mukhopadhyay, Rakesh K Tyagi.   

Abstract

Pregnane and Xenobiotic Receptor (PXR) is a transcription factor that is activated by a diverse range of xenobiotics and endogenous metabolites including steroids, bile acids and about 50% of the prescription drugs. In specific cell types (e.g. liver and intestine) it serves as a 'xenosensor' by regulating expression of a network of genes involved in xenobiotic clearance from the body. PXR expression in several cancerous tissues and its regulated expression of multi-drug resistance proteins highlight its significance in prognosis of malignancies. The view that subcellular localization and ligand induced movements of transcription factors is one of the major phenomena in regulating transcriptional activity, we used a green fluorescent protein tagged PXR chimera to study its dynamic behaviour in living cells. Under all experimental conditions, PXR was observed to be a predominantly nuclear protein maintaining a dynamic equilibrium between the nuclear and cytoplasmic compartments of the interphase cells. Interestingly, for the first time, a member of the nuclear receptor superfamily, PXR, has been observed to be associated with condensed chromosomes during all the mitotic stages of cell division. The significance of PXR association with mitotic chromosomes is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297466     DOI: 10.1016/j.bbamcr.2005.10.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Nuclear localization signal region in nuclear receptor PXR governs the receptor association with mitotic chromatin.

Authors:  Manjul Rana; Amit K Dash; Kalaiarasan Ponnusamy; Rakesh K Tyagi
Journal:  Chromosome Res       Date:  2018-07-15       Impact factor: 5.239

Review 2.  Mechanisms of xenobiotic receptor activation: Direct vs. indirect.

Authors:  Bryan Mackowiak; Hongbing Wang
Journal:  Biochim Biophys Acta       Date:  2016-02-10

Review 3.  Activation of xenobiotic receptors: driving into the nucleus.

Authors:  Haishan Li; Hongbing Wang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-04       Impact factor: 4.481

4.  Novel Application of Red Fluorescent Protein (DsRed-Express) for the Study of Functional Dynamics of Nuclear Receptors.

Authors:  Amit K Dash; Ashutosh S Yende; Rakesh K Tyagi
Journal:  J Fluoresc       Date:  2017-05-03       Impact factor: 2.217

5.  Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders.

Authors:  Nagendra Kumar Chaturvedi; Sanjay Kumar; Seema Negi; Rakesh K Tyagi
Journal:  Mol Cell Biochem       Date:  2010-09-10       Impact factor: 3.396

Review 6.  Role of CAR and PXR in xenobiotic sensing and metabolism.

Authors:  Yue-Ming Wang; Su Sien Ong; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-05-03       Impact factor: 4.481

7.  Cell-cycle-dependent regulation of androgen receptor function.

Authors:  Yulia Koryakina; Karen E Knudsen; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2015-02-17       Impact factor: 5.678

Review 8.  Overcoming drug resistance by regulating nuclear receptors.

Authors:  Taosheng Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

9.  Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.

Authors:  Wenwei Lin; Jing Wu; Hanqing Dong; David Bouck; Fu-Yue Zeng; Taosheng Chen
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

Review 10.  The constitutive androstane receptor and pregnane X receptor in the brain.

Authors:  Pablo Torres-Vergara; Yu Siong Ho; Francisca Espinoza; Francisco Nualart; Carlos Escudero; Jeffrey Penny
Journal:  Br J Pharmacol       Date:  2020-04-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.